ACCUMULATION OF P53 PROTEIN IN NORMAL, DYSPLASTIC, AND NEOPLASTIC BARRETTS-ESOPHAGUS

被引:73
作者
KRISHNADATH, KK
TILANUS, HW
VANBLANKENSTEIN, M
BOSMAN, FT
MULDER, AH
机构
[1] ERASMUS UNIV ROTTERDAM, DEPT SURG, 3000 DR ROTTERDAM, NETHERLANDS
[2] ERASMUS UNIV ROTTERDAM, DEPT GASTROENTEROL, 3000 DR ROTTERDAM, NETHERLANDS
关键词
BARRETTS ESOPHAGUS; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; P53; IMMUNOHISTOCHEMISTRY;
D O I
10.1002/path.1711750204
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Accumulation of p53 protein was determined by immunohistochemistry in archival material of biopsy specimens from 102 patients with Barrett's oesophagus with different grades of dysplasia, in 24 oesophageal adenocarcinomas associated with Barrett's oesophagus, and in 23 cases of metaplastic epithelium adjacent to these carcinomas. Immunostaining for the p53 protein was found in 23/102 (23 per cent) cases of the Barrett's oesophagus biopsies and in 12/23 (52 per cent) cases of Barrett's oesophagus adjacent to adenocarcinoma. Significant correlations were found between the grade of dysplasia and p53 immunoreactivity in both Barrett's biopsies without adenocarcinoma (P<0.001) and Barrett's oesophagus adjacent to adenocarcinoma (P<0.05). In the adenocarcinomas, intense nuclear immunohistochemical staining for p53 was diffusely or focally present in 20/24 (83 per cent) of the specimens. In Barrett's oesophagus, p53 is a progression marker with high expression in high-grade dysplasia (89 per cent) and adenocarcinoma (83 per cent).
引用
收藏
页码:175 / 180
页数:6
相关论文
共 30 条
[1]   EVALUATION OF 6 ANTIBODIES FOR IMMUNOHISTOCHEMISTRY OF MUTANT P53 GENE-PRODUCT IN ARCHIVAL COLORECTAL NEOPLASMS [J].
BAAS, IO ;
MULDER, JWR ;
OFFERHAUS, GJA ;
VOGELSTEIN, B ;
HAMILTON, SR .
JOURNAL OF PATHOLOGY, 1994, 172 (01) :5-12
[2]   CHRONIC PEPTIC ULCER OF THE OESOPHAGUS AND OESOPHAGITIS [J].
BARRETT, NR .
BRITISH JOURNAL OF SURGERY, 1950, 38 (150) :175-182
[3]  
BLOUNT PL, 1991, CANCER RES, V51, P5482
[4]  
CAAMANO J, 1991, AM J PATHOL, V139, P839
[5]  
CAMPO E, 1991, CANCER RES, V51, P4436
[6]  
CASSON AG, 1991, CANCER RES, V51, P4495
[7]  
FENNERTY MB, 1993, ALIMENT PHARM THER, V7, P339
[8]   ACTIVATING MUTATIONS FOR TRANSFORMATION BY P53 PRODUCE A GENE-PRODUCT THAT FORMS AN HSC70-P53 COMPLEX WITH AN ALTERED HALF-LIFE [J].
FINLAY, CA ;
HINDS, PW ;
TAN, TH ;
ELIYAHU, D ;
OREN, M ;
LEVINE, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (02) :531-539
[9]   OVEREXPRESSION OF P53 PROTEIN IN BARRETTS SYNDROME WITH MALIGNANT TRANSFORMATION [J].
FLEJOU, JF ;
POTET, F ;
MUZEAU, F ;
LEPELLETIER, F ;
FEKETE, F ;
HENIN, D .
JOURNAL OF CLINICAL PATHOLOGY, 1993, 46 (04) :330-333
[10]   ADENOCARCINOMA ARISING IN BARRETTS-ESOPHAGUS - EVIDENCE FOR THE PARTICIPATION OF P53 DYSFUNCTION IN THE DYSPLASIA/CARCINOMA SEQUENCE [J].
HARDWICK, RH ;
SHEPHERD, NA ;
MOORGHEN, M ;
NEWCOMB, PV ;
ALDERSON, D .
GUT, 1994, 35 (06) :764-768